FT
BLUE

Fiduciary Trust’s bluebird bio BLUE Stock Holding History

Fiduciary Trust’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-755
Closed -$7.84K – 695
2024
Q3 		$7.84K Hold
755
– – ﹤0.01% 654
2024
Q2 		$14.9K Hold
755
– – ﹤0.01% 629
2024
Q1 		$19.3K Hold
755
– – ﹤0.01% 642
2023
Q4 		$20.8K Hold
755
– – ﹤0.01% 621
2023
Q3 		$45.9K Hold
755
– – ﹤0.01% 605
2023
Q2 		$49.7K Hold
755
– – ﹤0.01% 619
2023
Q1 		$48K Hold
755
– – ﹤0.01% 609
2022
Q4 		$105K Buy
+755
New +$106K ﹤0.01% 611
2022
Q1 		– Sell
-1,114
Closed -$223K – 669
2021
Q4 		$223K Sell
1,114
-606
-35% -$143K ﹤0.01% 617
2021
Q3 		$426K Sell
1,720
-123
-7% -$35.2K 0.01% 496
2021
Q2 		$764K Hold
1,843
– – 0.01% 381
2021
Q1 		$720K Buy
1,843
+57
+3% +$28.1K 0.01% 392
2020
Q4 		$1M Buy
1,786
+69
+4% +$43.7K 0.02% 319
2020
Q3 		$1.2M Buy
1,717
+11
+0.6% +$8.58K 0.03% 266
2020
Q2 		$1.35M Buy
1,706
+43
+3% +$32.4K 0.03% 249
2020
Q1 		$990K Buy
+1,663
New +$1.62M 0.03% 263
2016
Q1 		– Sell
-772
Closed -$642K – 426
2015
Q4 		$642K Buy
772
+77
+11% +$76.9K 0.03% 273
2015
Q3 		$770K Sell
695
-2,779
-80% -$5.07M 0.03% 238
2015
Q2 		$7.58M Sell
3,474
-39
-1% -$79.4K 0.32% 79
2015
Q1 		$5.5M Sell
3,513
-191
-5% -$252K 0.23% 101
2014
Q4 		$4.4M Sell
3,704
-77
-2% -$51.5K 0.19% 108
2014
Q3 		$1.76M Sell
3,781
-58
-2% -$26.8K 0.08% 155
2014
Q2 		$1.92M Sell
3,839
-58
-1% -$18.6K 0.08% 152
2014
Q1 		$1.15M Buy
+3,897
New +$1.18M 0.05% 175

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Fiduciary Trust's BLUE Position: Q4 2024 in Review

Fiduciary Trust sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 755 shares — an estimated $7.84K sold.

Fiduciary Trust first reported a position in BLUE in Q1 2014 and held it in 24 quarters. The position peaked at $7.58M in Q2 2015. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Fiduciary Trust reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Fiduciary Trust sold 755 bluebird bio shares in Q4 2024, an estimated $7.84K.
  • Fiduciary Trust first reported a position in bluebird bio in Q1 2014 and held it in 24 quarters.
  • Fiduciary Trust's bluebird bio position peaked at $7.58M in Q2 2015.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Fiduciary Trust's 13F filing for Q4 2024, filed 14 Feb 2025.